Loading organizations...
Loading organizations...
Developing novel antibacterial resistance-breakers for drug-resistant infec
Antabio has raised $33.0M across 2 funding rounds.
Antabio has raised $33.0M in total across 2 funding rounds.
Antabio has raised $33.0M in total across 2 funding rounds.
Antabio's investors include Christophe Ricard, AMR Action Fund, BNP Paribas Développement, EIC Fund, IRDI Capital Investissement, Turenne Capital, Galia Gestion, Omnes Capital.
Antabio has raised $33.0M across 2 funding rounds. Most recently, it raised $26.9M Series B in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 12, 2023 | $26.9M Series B | Christophe Ricard, AMR Action Fund, BNP Paribas Développement, EIC Fund, IRDI Capital Investissement, Turenne Capital | |
| Jul 12, 2018 | $6.1M Series A Extension | BNP Paribas Développement, Galia Gestion, Omnes Capital, Turenne Capital |